Search by Drug Name or NDC

    NDC 63323-0579-05 SINCALIDE 5 ug/5mL Details

    SINCALIDE 5 ug/5mL

    SINCALIDE is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is SINCALIDE.

    Product Information

    NDC 63323-0579
    Product ID 63323-579_efc423ee-f932-45d4-9fd2-d4b4c350f5db
    Associated GPIs
    GCN Sequence Number 003097
    GCN Sequence Number Description sincalide VIAL 5 MCG INJECTION
    HIC3 D7B
    HIC3 Description CHOLERETICS
    GCN 09830
    HICL Sequence Number 001372
    HICL Sequence Number Description SINCALIDE
    Brand/Generic Generic
    Proprietary Name SINCALIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name sincalide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 5
    Active Ingredient Units ug/5mL
    Substance Name SINCALIDE
    Labeler Name Fresenius Kabi USA, LLC
    Pharmaceutical Class Cholecystokinin Analog [EPC], Cholecystokinin [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA017697
    Listing Certified Through 2024-12-31

    Package

    NDC 63323-0579-05 (63323057905)

    NDC Package Code 63323-579-05
    Billing NDC 63323057905
    Package 10 VIAL in 1 PACKAGE (63323-579-05) / 5 mL in 1 VIAL (63323-579-01)
    Marketing Start Date 2023-04-01
    NDC Exclude Flag N
    Pricing Information N/A